Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis.
Chang X, Deng W, Ni W, Li C, Han W, Gao LR, Wang S, Zhou Z, Chen D, Feng Q, Bi N, Gao S, Lin Y, Chen J, Xiao Z. Chang X, et al. Ann Surg Oncol. 2021 Nov;28(12):7076-7086. doi: 10.1245/s10434-021-10046-6. Epub 2021 May 9. Ann Surg Oncol. 2021. PMID: 33969465
[Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy].
Li C, Tan LJ, Liu X, Han WM, Gao LR, Wang SJ, Zhou ZM, Feng QF, Chen DF, Liang J, Lyu JM, Wang WQ, Hui ZG, Wang LH, Wang X, Liu WY, Deng L, Wang JY, Zhai YR, Zhang T, Bi N, Xiao ZF. Li C, et al. Zhonghua Zhong Liu Za Zhi. 2021 Jun 23;43(6):678-684. doi: 10.3760/cma.j.cn112152-20201031-00952. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34289560 Chinese.
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
Li C, Wang X, Wang X, Han C, Wang P, Pang Q, Chen J, Sun X, Wang L, Zhang W, Lin Y, Ge X, Zhou Z, Ni W, Chang X, Liang J, Deng L, Wang W, Zhao Y, Xiao Z. Li C, et al. BMC Cancer. 2019 Apr 29;19(1):397. doi: 10.1186/s12885-019-5544-1. BMC Cancer. 2019. PMID: 31036088 Free PMC article. Clinical Trial.
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Chang X, Deng W, Wang X, Zhou Z, Yang J, Guo W, Liu M, Qi X, Li L, Zhang K, Zhang M, Shi Y, Liu K, Zhao Y, Wang H, Yu Z, Zhang J, Wang L, Qiao X, Han C, Zhu S, Zhang R, Chen J, Hu C, Zhang F, Hou X, Pang Q, Zhang W, Li G, Lin H, Sun X, Ge X, Li C, Ge H, Li D, Wang Y, Lu N, Gao X, Qin S, Tian Y, Xiao Z. Chang X, et al. Radiat Oncol. 2021 Jun 9;16(1):102. doi: 10.1186/s13014-020-01691-4. Radiat Oncol. 2021. PMID: 34107984 Free PMC article.
[Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)].
Hu MM, Yuan QQ, Zhang XS, Yang S, Wang X, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Xu YG, Hao CL, Zhou ZG, Qie S, Lu N, Pang QS, Zhao YD, Sun XC, Li GF, Li L, Qiao XY, Liu ML, Wang YD, Li C, Zhu SC, Han C, Zhang KX, Xiao ZF. Hu MM, et al. Zhonghua Zhong Liu Za Zhi. 2020 Aug 23;42(8):676-681. doi: 10.3760/cma.j.cn112152-20190327-00197. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32867461 Chinese.
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.
Li C, Tan L, Liu X, Wang X, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Wang X, Bi N, Deng L, Wang W, Zhang T, Ni W, Chang X, Han W, Gao L, Wang S, Xiao Z. Li C, et al. Thorac Cancer. 2021 Jun;12(12):1831-1840. doi: 10.1111/1759-7714.13971. Epub 2021 May 5. Thorac Cancer. 2021. PMID: 33949784 Free PMC article.
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Gao LR, Wang X, Han W, Deng W, Li C, Wang X, Zhao Y, Ni W, Chang X, Zhou Z, Deng L, Wang W, Liu W, Liang J, Zhang T, Bi N, Wang J, Zhai Y, Feng Q, Lv J, Li L, Xiao Z. Gao LR, et al. BMC Cancer. 2020 Sep 22;20(1):901. doi: 10.1186/s12885-020-07387-y. BMC Cancer. 2020. PMID: 32962674 Free PMC article. Clinical Trial.